65,437 trials
Iron Deficiency Anemia
Primary: Participants Who Achieved A ≥2.0 g/dL Increase In Hemoglobin At Any Time From Baseline To Week 5 — 291; 117; 327; 145 Participants — p=0.2833
Multiple Myeloma
Primary: Percentage of Participants With Progression-free Survival (PFS) — 58.5; 57.8; 53.9 percentage of participants — p=0.87
Chronic Pain · Post-operative Pain
Primary: Time to Pain Resolution — 17; 15 DAYS
Nonconvulsive Seizures
Primary: Percentage of Subjects Who Experience no Nonconvulsive Seizures (NCS) for 24 Hours Following Treatment With LCM vs. fPHT, as Measured by Continuous…
Tourette Disorder · Tourette Syndrome
Primary: Yale Global Tic Severity Scale (YGTSS) — 24.72; 23.56; 15.00; 12.94 units on a scale
Hiv · HIV/AIDS
Primary: Number of Participants That Were Enrolled of Those Screened — 20 Participants
Non-ST Elevation Myocardial Infarction
Primary: Area Under Curve of Serial Cardiac Biomarkers — 197.2; 38.0; 121.4; 252.5 Hours*ng/ml
Diabetes Mellitus, Type 2
Primary: Fasting Blood Glucose (FBG) Level at Week 12 Endpoint as Measured by the 8-Point Self-Monitored Blood Glucose (SMBG) Profiles — 6.83; 7.15; 6.84 millimoles per Liter…
Melanoma
Primary: Objective Response Rate (ORR) — 22 percentage of patients
Depressive Disorder · Depression · Depressive Disorder, Major
Primary: Montgomery Asberg Depression Rating Scale (MADRS) — -6.04; -4.86; -4.57 Units on a scale — p=0.0078
Symptomatic Uterine Fibroids and Adenomyosis
Primary: Evaluation of Maximum Pain Intensity Change Over 24 Hours With the Addition of IV Acetaminophen and IV Ibuprofen — 6.48; 7.27; 6.16; 5.30 units on a scale
Cigarette Smoking · Tobacco Smoking · Tobacco Use Disorder
Primary: Tobacco Abstinence - 6 Month Follow-up — 105; 113 Participants — p=>0.05
Pseudohypoparathyroidism · Albright Hereditary Osteodystrophy
Primary: Intelligence Quotient — 85.9; 104.3; 103.2 units on a scale
Cardiovascular Disease · Hypercholesterolemia · Obesity
Primary: Change in Body Mass Index BMI Percentile — -1.12; -0.08; -1.29; -0.73 BMI percentile
Fetus or Neonate Affected by Maternal Epidural Anesthesia During Labor and Delivery
Primary: Incidence of New-onset Category II or III Fetal Heart Rate Tracings — 72; 52 Participants